CorMedix Inc. CRMD
Set alert
5.39 USD -0.31 -5.36%
At close
5.40 +0.01 +0.19%
Pre-market · Nov 3, 4:08 AM ET
5.34 Day range 5.75
5.34 52-week range 13.02
- YTD
- -53.65%
- 1 year
- -53.29%
- Open
- 5.70
- Prev close
- 5.70
- Mkt cap
- 420.12M
- Vol
- 3.30M
- Avg vol
- 1.23M
- EPS
- 1.94
- P/E
- 2.78
- Div yield
- 0.00%
More statistics
- Low
- 5.34
- High
- 5.75
- Forward P/E
- 17.54
- Beta
- 1.58
- Short ratio
- 5.12
- Inst. own
- 31.92%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 10.35
- 200-d avg
- 6.57
- 1y target
- 16.25
MAX chart
Events in this range
- May 6, 2025Earnings: 0.3; estimate 0.25; surprise 20%
- Aug 7, 2025Earnings: 0.28; estimate 0.2; surprise 40%
Signals (73)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Feb 1, 2026 | 9 months ago |
| SMA: Bearish | Jan 1, 2026 | 10 months ago |
| MACD: Sell Signal | Jan 1, 2026 | 10 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| SMA: Bearish | Nov 1, 2025 | 1 year ago |
| SMA: Bullish | Apr 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| RSI: Overbought | Oct 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 1, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| SMA: Bullish | Jul 1, 2023 | 3 years ago |
| SMA: Bearish | Jun 1, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 1, 2023 | 3 years ago |
| SMA: Bullish | Nov 1, 2022 | 4 years ago |
| SMA: Bearish | Aug 1, 2022 | 4 years ago |
Newest 20 of 73.
Financial health
Altman Z-Score
2.08 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 2
- P/E 4
- P/B 4
Valuation
P/E 5.2×
FY 2016 5y median -5.7× FY 2025
P/S 2.7×
FY 2016 5y median 11.0× FY 2025
P/B 2.1×
FY 2016 5y median 2.7× FY 2025
P/FCF 4.8×
FY 2016 5y median -6.9× FY 2025
EV/EBITDA 5.0×
FY 2016 5y median -4.0× FY 2025
EV/Sales 2.7×
FY 2016 5y median 10.0× FY 2025
FCF Yield 20.6%
FY 2016 5y median -13.2% FY 2025
Profitability
Gross Margin 88.5%
FY 2016 5y median 88.5% FY 2025
Operating Margin 48.2%
FY 2016 5y median -51.4% FY 2025
Net Margin 52.3%
FY 2016 5y median -41.2% FY 2025
ROE 40.2%
FY 2016 5y median -44.9% FY 2025
ROIC 23.0%
FY 2016 5y median -44.2% FY 2025
ROA 19.7%
FY 2016 5y median -40.9% FY 2025
Growth (YoY)
Revenue 617.0%
FY 2016 FY 2025
Operating Income 771.6%
FY 2016 FY 2025
EPS (diluted) 780.0%
FY 2016 FY 2025
Free Cash Flow 440.6%
FY 2016 FY 2025
Financial Health
Current Ratio 2.1×
FY 2016 5y median 7.0× FY 2025
Quick Ratio 1.9×
FY 2016 5y median 6.8× FY 2025
Debt / Equity 0.4×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.0×
FY 2016 5y median 1.4× FY 2025
Interest Coverage 54.0×
FY 2016 5y median -1155× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
